A systematic review and meta-analysis to compare the efficacy of acyclovir 3% ophthalmic ointment to idoxuridine in curing herpetic keratitis by Day 7 of treatment

BMC Ophthalmology

Volumn 15, Issue 1, 2015, Pages

  Balderson, Diane E ^a   Cai, Gengqian ^a   Fries, Michael A ^b   Kleinman, David M ^c   McLaughlin, Megan M ^a   Trivedi, Trupti M ^a   Wurzelmann, John I ^a   Young, Sheila B ^a  

^a GLAXOSMITHKLINE   (United States)

^b CSL Behring LLC   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acyclovir; Dendritic Keratitis; Geographic ulcers; Herpetic Keratitis; Ointment

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; IDOXURIDINE; OINTMENT;

FOLLOW UP; HUMAN; KERATITIS, HERPETIC; META ANALYSIS; OINTMENT; TIME FACTOR; TREATMENT OUTCOME;

ACYCLOVIR; ANTIVIRAL AGENTS; FOLLOW-UP STUDIES; HUMANS; IDOXURIDINE; KERATITIS, HERPETIC; OINTMENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930635419     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/s12886-015-0022-2     Document Type: Article

References (32)

1. Wilhelmus KR. Therapeutic interventions for herpes simplex virus epithelial keratitis (Review). s.l. Cochrane Database Syst Rev. 2009;1:1-134.
2. Macnab, Angus. Ulceration of the Cornea. s.l.: W. Wood, New York, 1907.
3. Lee SY, Pavan-Langston D. Role of aciclovir in the treatment of herpes simplex keratitis. Int Ophthalmol Clin. 1994;34(3):9-17.
4. Vajpayee RB, Dhakal BP, Gupta SK, Sachdev MS, Satpathy G, Honovar SG, et al. Evaluation of topical 0.03% flurbiprofen drops in the treatment of herpetic stromal keratitis. Austr NZ J Ophthalmol. 1996;24:131-5.
5. Knickelbein. Management of herpes simplex virus stromal keratitis: An evidence-based review. Surv Ophthalmol. 2009;54:226.
6. Kaufman HE, Martola EL, Dohlman CH. Use of IDU in treatment of herpes simplex keratitis. Arch Ophthalmol. 1962;68:235-9.
7. Burns RP. A double-blind study of IDU in human herpes simplex keratitis. Arch Ophthalmol. 1963;78:381-4.
8. Patterson A, Fox AD, Davies G, Maguire C, Holmessellers PJ, Wright P, et al. Controlled studies of IDU in the treatment of herpetic keratitis. UK: s.n. Trans Ophthalmol Soc UK. 1963;83:583-91.
9. Laibson PR, Leopold IH. An evaluation of double-blind IDU therapy in 100 cases of herpetic, keratitis. Trans Am Acad Ophthalmol Otolaryngol. 1964;68:22-34.
10. Hart DRL, Brightman VJF, Readshaw GG, Porter GTJ, Tully MJ. Treatment of human herpes simplex keratitis with idoxuridine. Arch Ophthalmol. 1965;73:623-34.
11. Ohashi Y. Treatment of herpetic keratitis with acyclovir: benefits and problems. Ophthalmologica. 1997;Suppl. 1 211:29-32.
12. eMC. eMC: Zovirax eye Ointment Summary of Product Characteristics, 2012. [Online] 2012. [Cited: 10 2, 2013.] http://www.medicines.org.uk/emc/medicine/2187/SPC#PRODUCTINFO.
13. DailyMed. DailyMed: Dendrid (idoxuridine) Solution/Drops, 2006. DailyMed. [Online] nih, 2006. [Cited: 10 2, 2013.] http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3537dd95-954-459f-97a9-54a861bed265.
14. Barker NH. Ocular herpes simplex. Clin Evid. 2008;2008:0707.
15. Guess S, Stone DU, Chodosh J. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. 2007;5:240-50.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, vol. 339. London: BMJ Publishing Group Ltd, 2009. BMJ. 2009;339:332-6. ISSN 1756 5833.
17. Cochran WB. Some methods for strengthening the common chi-square tests. Biometrics. 1954;10:417-51.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Inst. 1959;22:719-48.
19. Breslow, NE and Day, NE. The analysis of case-control studies. Statistical methods in cancer research. s.l.: International Agency for Research on Cancer Scientific Publications, Lyon, 1980; 1:1-32.
20. Tarone RE. On heterogenetiy tests based on efficient scores. Biometrika. 1985;72:91-5.
21. Colin J, Tourmoux A, Chastel C, Renard G. Superficial herpes-simplex keratitis: double-blind comparative trial of acyclovir and idoxuridine. Nour Pres Med. 1981;10:2969-75.
22. Collum LM, Benedict-Smith A, Hillary IB. Randomized double-blind trial of acyclovir and idosuridine in dendrtic corneal ulceration. Br J Ophthalmol. 1980;64:766-9.
23. Coster DJ, Wilhelmus KR, Michaud R, Jones BR. A comparison of acyclovir and idosuridine as treatment of ulcerative herpetic keratitis. Br J Opthalmol. 1980;64:763-5.
24. Hamard. Brief summary of French report of a double blind clinical trial comparing acyclovir and idoxuridine in herpetic keratitis. GSK internal report. 1982.
25. Kitano S. Efficacy of acyclovir in dendritic keratitis: a double-blind comparative study with IDU. Ther Res. 1985;2:643-7.
26. Klauber A, Ottovay E. Acyclovir and idoxuridine treatment of herpes simplex keratitis - a double blind clinical study. Acta Ophthalmol. 1982;60:838-44.
27. McCulley JP, Binder PS, Kaufman HE, O'Day DM, Poirier RH. A double blind, multicenter clinical trial of acyclovir vs idoxuridine for treatment of epithelial herpes simplex keratitis. Ophthalmology. 1982;89:1195-200.
28. Wilhelmus KR. Antiviral treatment and othe rtherapeutic interventions for herpes simplex virus epithelial keratitis. s.l. Cochrane Database Syst Rev. 2010;12:1-243.
29. Poirer RH, Kingham JD, de Miranda P, Annel M. Intraocular antiviral penetration. Arch Ophthalmol. 1982;100:1964-7.
30. Luntz MH, MacCallum FO. Treatment of herpes simplex keratitis with 5-iodo-2′-deoxyuridine. Br J Ophthalmol. 1963;47:449-56.
31. Wilhelmus KR, Coster DJ, Jones BR. Acyclovir and debridement in the treatment of ulcerative herpetic keratitis. Am J Ophthalmol. 1981;91:323-7.
32. Markham RH, Carter C, Scobie MA, Metcalf C, Easty DL. Double-blind clinical trial of adenine arabinoside and idoxuridine in herpetic corneal ulcers. Trans Ophthal Suc UK. 1977;97:333-40.